Small Molecules in Hematology

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology, Oncology
Cover of the book Small Molecules in Hematology by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319914398
Publisher: Springer International Publishing Publication: August 1, 2018
Imprint: Springer Language: English
Author:
ISBN: 9783319914398
Publisher: Springer International Publishing
Publication: August 1, 2018
Imprint: Springer
Language: English

This book, written by respected experts, discusses in detail the latest developments in targeted therapy for hematologic malignancies using small molecules. It covers a wide range of small molecules including tyrosine kinase inhibitors, immunomodulatory drugs, the IDH-2 inhibitor enasidenib, the BCL-2 inhibitor venetoclax, and the proteasome inhibitor carfilzomib. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. 

Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of precision cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. An accompanying volume addresses the use of small molecules in oncology, and the two volumes together represent the third edition of the book originally published under the same title. 

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book, written by respected experts, discusses in detail the latest developments in targeted therapy for hematologic malignancies using small molecules. It covers a wide range of small molecules including tyrosine kinase inhibitors, immunomodulatory drugs, the IDH-2 inhibitor enasidenib, the BCL-2 inhibitor venetoclax, and the proteasome inhibitor carfilzomib. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. 

Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of precision cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. An accompanying volume addresses the use of small molecules in oncology, and the two volumes together represent the third edition of the book originally published under the same title. 

More books from Springer International Publishing

Cover of the book Introduction to Multiphase Flow by
Cover of the book The Political Thought of C.B. Macpherson by
Cover of the book Prior Processes and Their Applications by
Cover of the book The Energy Transition by
Cover of the book Landscapes and Landforms of Colombia by
Cover of the book Challenges in Mechanics of Time Dependent Materials, Volume 2 by
Cover of the book Multi-Targeted Approach to Treatment of Cancer by
Cover of the book Quantum Spin Systems on Infinite Lattices by
Cover of the book Smart Growth and Sustainable Development by
Cover of the book Immigrants in the Sexual Revolution by
Cover of the book Inclusive Leadership by
Cover of the book Lectures on Complex Integration by
Cover of the book Social Manufacturing: Fundamentals and Applications by
Cover of the book The Structural Integrity of Carbon Fiber Composites by
Cover of the book Mathematical Tablets from Tell Harmal by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy